Some Healthcare Stocks in Focus: Aster DM, Bayer CropScience & More

  • Stock Market News
Some Healthcare Stocks in Focus: Aster DM, Bayer CropScience & More
Credit: © Reuters.

By Malvika Gurung -- Bayer (ETR: BAYGN ) Cropscience (NS: BAYE ): The multinational pharmaceuticals company’s profit jumped 146.7% YoY to Rs 152.7 crore in the March quarter and revenue from operations surged 31.3% YoY to Rs 963.3 crore.

Dr. Reddy’s Laboratories (NS: REDY ): The pharmaceutical giant, in partnership with Senores Pharmaceuticals, has launched Ketorolac Tromethamine tablets in the U.S. market, post-approval by the US FDA.

Metropolis Healthcare (NS: METP ): The diagnostic chain’s consolidated net profit declined 34% YoY to Rs 40 crore, and revenue climbed 5% YoY to Rs 306 crore in the March quarter, both falling short of the Street’s expectations. Its total cost surged 20% YoY to Rs 255 crore in the period.

Ipca Laboratories (NS: IPCA ): The company’s consolidated net PAT declined 19.3% YoY to Rs 130.23 crore in Q4, due to higher expenses., while revenue rose 15.6% YoY to Rs 1,289.1 crore in the quarter. Further, its board has approved the merger of Tonira Exports and Ramdev Chemical, subject to approval.

Aster DM Healthcare (NS: ATRD ): The healthcare company’s consolidated net profit rallied a whopping 110.25% YoY to Rs 246 crore in the March quarter, while its revenue from operations rose 14.1% YoY to Rs 2,728 crore.

Companies including Torrent Pharma (NS: TORP ), Apollo Hospitals (NS: APLH ), Max Healthcare (NS: MAXE ), and Fortis Healthcare (NS: FOHE ) will release their earnings results for the March-ending quarter on May 25.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or


Related Articles